Invitrogen Positions New Array System for HLA Research Market

The Life Technologies unit said that its new Prodigy system should support the use of human leukocyte antigen testing in histocompatibility research, vaccine and drug development, and disease-association studies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.